Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2022-10-07 00:00:00 ET · period of report 2022-10-06 · accession 0001562180-22-007125 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-10-07 | 2022-10-06 | SNDX | Katkin Keith | Dir | M - OptEx | $8.20 | +29.9K | 52.8K | +131% | +$245.2K |
| DM | 2022-10-07 | 2022-10-06 | SNDX | Katkin Keith | Dir | S - Sale+OE | $25.90 | -29.9K | 32.0K | -48% | -$774.4K |
| DM | 2022-10-07 | 2022-10-06 | SNDX | Katkin Keith | Dir | M - OptEx | $0.00 | -29.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-06 | M | A | 9,117 | $8.93 | 41,117 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-06 | S | D | 20,782 | $25.90 | 32,000 | D | — | — | (F2) The sale prices ranged from $25.0000 to $26.4600. |
| 3 | Common | Common Stock | 2022-10-06 | S | D | 9,117 | $25.90 | 32,000 | D | — | — | (F2) The sale prices ranged from $25.0000 to $26.4600. |
| 4 | Common | Common Stock | 2022-10-06 | M | A | 20,782 | $7.88 | 52,782 | D | — | — | |
| 5 | Derivative | Stock Options (Right to buy) | 2022-10-06 | M | D | 9,117 | $0.00 | 0 | D | $8.93 · — to 2028-05-23 | 9,117 Common Stock | (F3) This option is fully vested. |
| 6 | Derivative | Stock Options (Right to buy) | 2022-10-06 | M | D | 20,782 | $0.00 | 0 | D | $7.88 · — to 2029-06-10 | 20,782 Common Stock | (F3) This option is fully vested. |